Literature DB >> 26415906

Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.

Helio S Sader1, Paul R Rhomberg2, David J Farrell2, Ronald N Jones2.   

Abstract

Gram-negative bacilli (n=15,377) were tested against colistin (polymyxin E) and polymyxin B by a commercial broth microdilution method (Sensititre®). Among Pseudomonas aeruginosa and Acinetobacter spp., colistin and polymyxin B MIC values were within ±1 doubling dilution for >99.0% of strains. Among Klebsiella spp. and Escherichia coli, 55.0 and 53.2% of strains displayed a colistin MIC 2-fold lower than polymyxin B, but polymyxin B was slightly more potent than colistin against strains with decreased susceptibility to either polymyxin.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Broth microdilution method; Polymyxins; Susceptibility testing

Mesh：

Substances：

Year:  2015        PMID： 26415906     DOI： 10.1016/j.diagmicrobio.2015.08.013

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  13 in total

Review 1.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?

Authors:  Michael J Satlin
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

3.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

4.  Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models.

Authors:  Cornelia B Landersdorfer; Jiping Wang; Veronika Wirth; Ke Chen; Keith S Kaye; Brian T Tsuji; Jian Li; Roger L Nation
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

5.  Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?

Authors:  Shawn Vasoo
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

6.  Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).

Authors:  Jason M Pogue; Ronald N Jones; John S Bradley; David R Andes; Sujata M Bhavnani; George L Drusano; Michael N Dudley; Robert K Flamm; Keith A Rodvold; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

7.  Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution.

Authors:  Ka Lip Chew; My-Van La; Raymond T P Lin; Jeanette W P Teo
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

Review 8.  Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Authors:  Alexandre P Zavascki; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

9.  International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

Authors:  Brian T Tsuji; Jason M Pogue; Alexandre P Zavascki; Mical Paul; George L Daikos; Alan Forrest; Daniele R Giacobbe; Claudio Viscoli; Helen Giamarellou; Ilias Karaiskos; Donald Kaye; Johan W Mouton; Vincent H Tam; Visanu Thamlikitkul; Richard G Wunderink; Jian Li; Roger L Nation; Keith S Kaye
Journal:  Pharmacotherapy       Date:  2019-01       Impact factor: 6.251

10.  Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics.

Authors:  Michelle M Bellerose; Andrew E Clark; Jung-Ho Youn; Rebecca A Weingarten; Chelsea M Crooks; John P Dekker; Karen M Frank
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.